These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22516463)

  • 21. Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
    Nunes MA; Schöwe NM; Monteiro-Silva KC; Baraldi-Tornisielo T; Souza SI; Balthazar J; Albuquerque MS; Caetano AL; Viel TA; Buck HS
    PLoS One; 2015; 10(11):e0142267. PubMed ID: 26605788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.
    Wang CM; Devries S; Camboni M; Glass M; Martin PT
    Neurobiol Dis; 2010 Sep; 39(3):409-22. PubMed ID: 20493257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
    Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease.
    Marlatt MW; Potter MC; Bayer TA; van Praag H; Lucassen PJ
    Curr Top Behav Neurosci; 2013; 15():313-40. PubMed ID: 23670818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of exercise training against the progression of Alzheimer's disease in 3xTg-AD mice.
    Kim D; Cho J; Kang H
    Behav Brain Res; 2019 Nov; 374():112105. PubMed ID: 31325514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner.
    Joseph DJ; Liu C; Peng J; Liang G; Wei H
    PLoS One; 2019; 14(10):e0223509. PubMed ID: 31600350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model.
    Chen B; Bromley-Brits K; He G; Cai F; Zhang X; Song W
    Curr Alzheimer Res; 2010 May; 7(3):255-61. PubMed ID: 20043809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
    Wang ZJ; Zhao F; Wang CF; Zhang XM; Xiao Y; Zhou F; Wu MN; Zhang J; Qi JS; Yang W
    J Alzheimers Dis; 2019; 72(4):1217-1231. PubMed ID: 31683484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
    Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.
    Caccamo A; Oddo S; Tran LX; LaFerla FM
    Am J Pathol; 2007 May; 170(5):1669-75. PubMed ID: 17456772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.
    Stojakovic A; Chang SY; Nesbitt J; Pichurin NP; Ostroot MA; Aikawa T; Kanekiyo T; Trushina E
    J Alzheimers Dis; 2021; 79(1):335-353. PubMed ID: 33285637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcranial direct current stimulation does not improve memory deficits or alter pathological hallmarks in a rodent model of Alzheimer's disease.
    Gondard E; Soto-Montenegro ML; Cassol A; Lozano AM; Hamani C
    J Psychiatr Res; 2019 Jul; 114():93-98. PubMed ID: 31054455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
    Baazaoui N; Iqbal K
    J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
    Fertan E; Wong AA; Vienneau NA; Brown RE
    Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Young blood plasma reduces Alzheimer's disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice.
    Zhao Y; Qian R; Zhang J; Liu F; Iqbal K; Dai CL; Gong CX
    Alzheimers Res Ther; 2020 Jun; 12(1):70. PubMed ID: 32513253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
    J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.